- CSR Summary Not Yet Available
- NCT00299702
- Primary Citation Not Available
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameRisperidoneProduct NameRISPERDAL CONSTA®Therapeutic AreaBehaviors and Mental DisordersEnrollment355% Female40.3%% WhiteN/A
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRISSCH4060Data PartnerJohnson & JohnsonCondition StudiedSchizophreniaMean/Median Age (Years)38
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available